|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008670,
umls-concept:C0022646,
umls-concept:C0036869,
umls-concept:C0332120,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0521115,
umls-concept:C0598174,
umls-concept:C1266045,
umls-concept:C1306837,
umls-concept:C1517378,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C1999230
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1997-8-15
|
|
pubmed:abstractText |
Metanephric adenoma has recently been recognized as a unique renal tumor characterized by an unusual degree of cellular differentiation and maturation. We recently studied metanephric adenoma using metaphase analysis and observed concomitant chromosome Y loss and chromosome 7 and 17 gain. To determine if these chromosomal anomalies are consistently present in renal metanephric adenoma, we studied all 11 tumors in the pathology tissue registry at our institution using fluorescence in situ hybridization (FISH).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
158
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
370-4
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9224305-Adenoma,
pubmed-meshheading:9224305-Carcinoma, Papillary,
pubmed-meshheading:9224305-Carcinoma, Renal Cell,
pubmed-meshheading:9224305-Chromosome Aberrations,
pubmed-meshheading:9224305-Chromosomes, Human, Pair 1,
pubmed-meshheading:9224305-Chromosomes, Human, Pair 17,
pubmed-meshheading:9224305-Chromosomes, Human, Pair 7,
pubmed-meshheading:9224305-Chromosomes, Human, Pair 8,
pubmed-meshheading:9224305-Female,
pubmed-meshheading:9224305-Humans,
pubmed-meshheading:9224305-In Situ Hybridization, Fluorescence,
pubmed-meshheading:9224305-Kidney Neoplasms,
pubmed-meshheading:9224305-Male,
pubmed-meshheading:9224305-Sex Chromosomes
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
|
|
pubmed:affiliation |
Department of Urology, Mayo Clinic, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article
|
